The per patient fee for Botulism Immune Globulin shall be $57,300 effective January 1, 2019, and $69,300 effective January 1, 2024.
Cal. Code Regs. Tit. 17, § 3030
2. Certificate of Compliance as to 6-3-98 order transmitted to OAL 9-23-98 and filed 11-4-98 (Register 98, No. 45).
3. Amendment of section and NOTE filed 4-26-2005; operative 5-1-2004. Submitted to OAL for printing only pursuant to Health and Safety Code section 123702(d) (Register 2005, No. 17).
4. Amendment of section and NOTE filed 1-10-2019; operative 1-1-2019. Submitted to OAL for filing and printing only pursuant to Health and Safety Code section 123702(d) (Register 2019, No. 2).
5. Amendment filed 4-1-2021; operative 4-1-2021. Submitted to OAL for filing and printing only pursuant to Health and Safety Code section 123702(d) (Register 2021, No. 14).
Note: Authority cited: Sections 100275, 123707(d), 131050, 131051, 131052 and 131200, Health and Safety Code. Reference: Sections 123702 and 123705, Health and Safety Code.
2. Certificate of Compliance as to 6-3-98 order transmitted to OAL 9-23-98 and filed 11-4-98 (Register 98, No. 45).
3. Amendment of section and Note filed 4-26-2005; operative 5-1-2004. Submitted to OAL for printing only pursuant to Health and Safety Code section 123702(d) (Register 2005, No. 17).
4. Amendment of section and Note filed 1-10-2019; operative 1/1/2019. Submitted to OAL for filing and printing only pursuant to Health and Safety Code section 123702(d) (Register 2019, No. 2).
5. Amendment filed 4-1-2021; operative 4/1/2021. Submitted to OAL for filing and printing only pursuant to Health and Safety Code section 123702(d) (Register 2021, No. 14).